14 C
New Delhi
HomeHealth & FitnessBioNTech faces first German lawsuit over alleged COVID vaccine side effects

BioNTech faces first German lawsuit over alleged COVID vaccine side effects

Even though BioNTech’s Comirnaty vaccine is the most trusted and used one by European Medicines Agency (EMA), a German woman (name not to be disclosed) has come forward to sue the German vaccine maker. She said that she noticed some bodily harm while the brand still sticks to the statement that said: “The positive benefit-risk profile of Comirnaty remains positive and the safety profile has been well characterized.”

Allegations On BioNtech due to COVID side-effects

The vaccine that has been used by over 1.5 billion people in the world and over 64 million people in Germany is now being sued because, under German privacy law, a woman has complained about suffering side effects like upper-body pain, fatigue, and sleeping, swollen extremities disorder due to the vaccine. However, the mentioned after-effects that have been noticed are headache, fever, muscle pain, and fatigue. Law firm Rogert & Ulbrich is representing her and the hearing on the same will be held on Monday in the regional court of Hamburg to see what can be done as she has asked for compensation of at least 150,000 euros.

Give this a read too – Heart Attacks: Study says Mondays can give you more serious heart attacks .

What Might Happen Due To This Lawsuit?

BioNTech is not staying behind in answering people’s questions and attending conferences because it looks like they want to sustain the trust they have built. And they have statistics to support their statements too like how the vaccine helped over 20 million people without any harmful effects afterward. However, it has not yet been clarified who and how will the compensation be managed if the woman wins the case.
The EMA and BioNTech are however not only discussing the myocarditis and pericarditis’s risk in young males as an effect but also, how some of the side effects might not have been noticed as the vaccine was worked on during the COVID-19 times. The long-term trials might come up with something undiscovered but since it has been regulatory approved, such chances are rare. The law firm associated has already questioned the assessment so the actions are going to be taken accordingly only.

For more about latest health and fitness updates, click here.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular